Downloadable Slideset

Share

Program Content

Activities

  • Evaluation of Prostate Cancer
    Contemporary Diagnostic Evaluation of Prostate Cancer: Role of Biomarker Testing and Imaging
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • Castration-Sensitive Prostate Cancer
    Optimal Management of Metastatic Castration-Sensitive Prostate Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • Emerging Agents for Prostate Cancer
    Emerging Agents and Reimagining Older Treatment Options for Prostate Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • PARP Inhibitors for CRPC
    Current and Emerging Role of PARP Inhibitors Alone or With Secondary Hormonal Therapies for Patients With mCRPC
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • PSMA-Targeting Treatment
    Current and Future Role of Radium-223 and PSMA-Targeting Treatment
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

Faculty

cover img faculity

Alan H. Bryce, MD

Chief Clinical Officer
Professor, Department of Medical Oncology and Therapeutics Research 
Professor of Molecular Medicine, TGEN
City of Hope
Phoenix, Arizona

cover img faculity

Tanya B. Dorff, MD

Professor of Medicine
Vice Chair for Clinical Affairs
Department of Medical Oncology
City of Hope National Medical Center
Duarte, California

cover img faculity

Karim Fizazi, MD, PhD

Full Professor
Cancer Medicine
Gustave Roussy
Villejuif, France

cover img faculity

Rana R. McKay, MD

Associate Professor of Medical Oncology and Urology
Associate Director, Clinical Sciences
Co-Lead, Genitourinary Malignancies Program
Moores Cancer Center
University of California San Diego
La Jolla, California

cover img faculity

Matthew R. Smith, MD, PhD

Professor of Medicine
Harvard Medical School
Director
Genitourinary Malignancies Program
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck Sharp & Dohme Corp., and Novartis Pharmaceuticals Corporation.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation